# A Study Evaluating the Effect of a Single-dose Oral Administration of Nemonoxacin Capsule on QTc Intervals and Heart Rhythms of Healthy Subjects and the Influence of Food Intake on QTc Intervals and Pharmacokinetic Characteristics

> **NCT03362853** · PHASE1 · COMPLETED · sponsor: **TaiGen Biotechnology Co., Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Nemonoxacin 500Mg Capsule
- **DRUG:** Moxifloxacin 400Mg Tablet
- **DRUG:** Nemonoxacin 750Mg Capsule
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03362853
- **Lead sponsor:** TaiGen Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06-25
- **Primary completion:** 2012-08-10
- **Final completion:** 2012-08-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03362853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03362853, "A Study Evaluating the Effect of a Single-dose Oral Administration of Nemonoxacin Capsule on QTc Intervals and Heart Rhythms of Healthy Subjects and the Influence of Food Intake on QTc Intervals and Pharmacokinetic Characteristics". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03362853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*